Clout Of Drug Industry Seen In MD Residency Programs And In Health Reform
Main Category: Pharma Industry / Biotech IndustryAlso Included In: Primary Care / General Practice; Medical Students / Training
Article Date: 24 Feb 2010 - 5:00 PDT
| Patient / Public: | ![]() |
|
| Healthcare Prof: | ![]() |
5 (2 votes) |
News outlets report on the pharmaceutical industry's involvement in doctor training and its role in shaping the health care overhauls pending in Congress.
The New York Times: "More than half of the nation's medical residency programs to train doctors in internal medicine accepted financial support from the drug industry, even though three-fourths of the programs' directors said accepting the aid was 'not desirable,' a survey found. At issue are potential conflicts of interest as the residency programs ... train tens of thousands of new doctors at a point in their careers when they are beginning to prescribe drugs..." The study, published Monday online in the Archives of Internal Medicine, was "conducted in 2006 and 2007 [and] found that drug companies paid for educational materials like pocket guides in 83 percent of the programs that accepted support," as well as meals, office supplies and drug samples (Wilson, 2/22).
NPR's Fresh Air talks with Sunlight Foundation senior writer Paul Blumenthal about the "secret deal" between the Pharmaceutical Research and Manufacturers of America (PhRMA), the White House and members of Congress in which "the pharmaceutical industry pledged to reduce health care costs by $80 billion over 10 years." Blumenthal explains the Obama administration put "'the biggest lobby in Washington on the side of health care reform.' Meanwhile, the pharmaceutical industry got a guarantee that 'Congress would not legislate any cost-cutting measures that would make a dent in industry profits.'" An investigation revealed that "Congress and PhRMA met dozens of times to negotiate that deal" (Gross, 2/22).
This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org.
© Henry J. Kaiser Family Foundation. All rights reserved.
Visit our pharma industry / biotech industry section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/180210.php>
APA
http://www.medicalnewstoday.com/releases/180210.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




